First eye drop for diabetic macular oedema on horizon after successful trial 30-Nov-2023 By Isabel Cameron Exonate, an mRNA therapy company focused on treatments for diabetic complications, has announced that its lead ophthalmology asset, EXN407, has achieved its prespecified endpoints in an early study.
Grifols and Selagine collaborate to produce 'game-changing' dry eye disease treatment 14-Mar-2023 By Liza Laws Grifols has entered into a collaboration and licensing agreement with Selagine to develop immunoglobulin (Ig) eye drops to treat dry eye disease.
Celanese partners with Johns Hopkins on eye drug delivery 20-Feb-2023 By Ben Hargreaves The partners will collaborate on a study of sustained drug delivery to the suprachoroidal space in the eye.